Neurothrombectomy
Neurothrombectomy is a medical device with 5 clinical trials. Historical success rate of 60.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
60.0%
3 of 5 finished
40.0%
2 ended early
0
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Prospective Registry for Assessment of Acute Ischemic Stroke Patients Treated With Neurothrombectomy Devices in India
ANAIS Study to Confirm the Safety and Performance of the ANA 5F Advanced Neurovascular Access®
Helping Stroke Patients With ThermoSuit Cooling
Assessing Safety and Performance of the ANA Catheter System, Combined With a Stent Retriever in Acute Ischemic Stroke
Post-Market Registry Of Stroke Patients Treated With Medtronic Neuro Thrombectomy Devices to Collect Real World Data in South East Asia
Clinical Trials (5)
Prospective Registry for Assessment of Acute Ischemic Stroke Patients Treated With Neurothrombectomy Devices in India
ANAIS Study to Confirm the Safety and Performance of the ANA 5F Advanced Neurovascular Access®
Helping Stroke Patients With ThermoSuit Cooling
Assessing Safety and Performance of the ANA Catheter System, Combined With a Stent Retriever in Acute Ischemic Stroke
Post-Market Registry Of Stroke Patients Treated With Medtronic Neuro Thrombectomy Devices to Collect Real World Data in South East Asia
All 5 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 5